Literature DB >> 7279785

Granuloblastomas of the stomach (so-called eosinophilic granulomas)-- a variant of fibrous histiocytomas?

F Bolck, D Katenkamp.   

Abstract

25 cases of focal connective tissue proliferations in the submucosa of the stomach are presented. These lesions are termed "granuloblastomas" and have many features in common with so-called eosinophilic granulomas of the stomach. We found that granuloblastomas may be subdivided into two groups: (1) 8 cases are considered to be the result of the proliferation of a peculiar granulation tissue with abundant eosionophilic granulocytes, and (2) 17 cases show a more or less marked storiform pattern and the cellularity is constituted by fibroblasts and histiocytes as well as differing amounts of eosinophilic granulocytes. After discussing the concept of "fibrous histiocytomas" it is concluded that at least the second group of granuloblastomas may be interpreted as a pseudotumorous variant of fibrous histiocytomas. It remains to be clarified in future if submucosal neurofibromas can show the histological features of lesions which we designate granuloblastomas.

Entities:  

Mesh:

Year:  1981        PMID: 7279785     DOI: 10.1016/S0344-0338(81)80106-9

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  3 in total

1.  Inflammatory myofibrohistiocytic proliferation presenting as giant gastric pseudotumor.

Authors:  C S Marn; F K Hsu
Journal:  Gastrointest Radiol       Date:  1992

Review 2.  [Inflammatory fibroid polyp: from Vanek's "submucosal granuloma" to the concept of submucosal mesenchymal neoplasia].

Authors:  H-U Schildhaus; S Merkelbach-Bruse; E Binot; R Büttner; E Wardelmann
Journal:  Pathologe       Date:  2010-03       Impact factor: 1.011

3.  Evaluation of clinico-pathological features and Helicobacter pylori infection in gastric inflammatory fibroid polyps.

Authors:  Andreia Albuquerque; Elisabete Rios; Fátima Carneiro; Guilherme Macedo
Journal:  Virchows Arch       Date:  2014-09-26       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.